Inteliview
Log inSign up
Topics

Ondas Posts Record Quarterly Revenue… 25 SEC Earnings Filings Received Today

25 SEC 8-K earnings filings were submitted on May 15, 2026. Ondas surged after posting record quarterly revenue, while Aveanna Healthcare, Legence, GameSquare, and others also reported quarterly results.

Justin Jeon··Updated May 15, 2026 at 21:42·10 min read
Also available in Korean한국어로 보기 →
ondas-record-revenue-sec-earnings-filings-may-15-2026
ondas-record-revenue-sec-earnings-filings-may-15-2026
AIKey Summary
  • Ondas (ONDS) surged after posting record quarterly revenue, topping estimates among 25 SEC 8-K filings on May 15
  • Cisco and Applied Materials also beat expectations, fueling a broad U.S
  • market rally

On Friday, May 15, 2026, 25 SEC 8-K Item 2.02 (earnings release) filings were submitted. Small- and mid-cap public companies spanning aviation, drones, biotech, healthcare, energy, and other sectors simultaneously disclosed their most recent quarterly results.


Today's SEC Earnings Filings

Ondas Inc. (ONDS) reported its latest quarterly results via an SEC 8-K Item 2.02 filing. According to The Motley Fool, Ondas posted record quarterly revenue, beating consensus estimates and sending shares sharply higher following the announcement. The results are seen as confirming the company's growth momentum as a specialist in drone and autonomous solutions.

Aveanna Healthcare Holdings, Inc. (AVAH) filed an 8-K under Items 2.02 and 7.01, disclosing its quarterly results. The home-based nursing services company's specific figures are available in the filing attachments. Legence Corp. (LGN) also reported quarterly results via an SEC 8-K Item 2.02 filing. The energy efficiency and building infrastructure services firm communicated its latest quarterly operating performance to investors.

Sky Harbour Group Corp filed an 8-K under Items 2.02 and 9.01, disclosing its quarterly results. The infrastructure company that develops and operates premium private aviation hangar campuses reported its latest quarterly business update through the SEC filing. York Space Systems Inc. (YSS) also submitted an 8-K filing, reporting its quarterly results. YSS, a satellite platform manufacturer attracting growing attention in the aerospace sector, disclosed its most recent quarterly performance.

In the biotech sector, Keros Therapeutics, Inc. (KROS), Celcuity Inc. (CELC), Jasper Therapeutics, Inc. (JSPR), Dogwood Therapeutics, Inc. (DWTX), Sangamo Therapeutics, Inc. (SGMO), Benitec Biopharma Inc. (BNTC), Invivyd, Inc. (IVVD), and First Tracks Biotherapeutics, Inc. (TRAX) each reported quarterly results via SEC 8-K Item 2.02 filings. Given the clinical-stage nature of these companies, R&D expenditure and cash runway are the key metrics commanding investor attention.

Additionally, Co-Diagnostics, Inc. (CODX), Ideal Power Inc. (IPWR), Harte-Hanks Inc. (HHS), FitLife Brands, Inc. (FTLF), Beeline Holdings, Inc. (BLNE), Unusual Machines, Inc. (UMAC), Laird Superfood, Inc. (LSF), Mount Logan Capital Inc. (MLCI), Actelis Networks Inc. (ASNS), Lithium Americas Corp. (LAC), Dragonfly Energy Holdings Corp. (DFLI), and GameSquare Holdings, Inc. (GAME) each disclosed quarterly results via SEC 8-K Item 2.02 filings. Earnings season continues across a diverse range of sectors including diagnostics, drones, nutrition, media, and energy storage.


Earnings Surprises & Guidance

According to The Motley Fool, Ondas (ONDS) delivered an earnings surprise, posting record quarterly revenue that exceeded market expectations. Shares surged following the announcement, generating strong market enthusiasm. Analysts attributed the outperformance to expanding demand for drone and rail automation solutions.

According to Investing.com, Applied Materials beat market expectations in Q2 FY2026 with strong EPS and revenue growth. Cisco Systems posted blowout earnings and raised its guidance, sending shares sharply higher, according to The Motley Fool. The strong results from both large-cap tech companies are seen as having driven a broad-based rally in U.S. equity markets.

On the downside, Eton Pharmaceuticals (ETON) missed Q1 EPS estimates, according to Yahoo Finance Canada. United States Antimony reported Q1 2026 results that fell short of market forecasts, per Investing.com. Vivara also missed Q1 expectations, with shares falling 12%, according to Investing.com.

According to Investing.com, KinderCare Learning topped Q1 2026 EPS estimates, sending shares higher, while HeartFlow and Construction Partners each beat market forecasts in their respective Q1 and Q2 results. An RBC analyst expressed optimism ahead of Nvidia's earnings release via TipRanks, highlighting the sustained demand outlook for AI semiconductors.


Korean Corporate Earnings

KB Securities set a target price of $301 (₩450,000) for Samsung Electronics, according to Chosunbiz, forecasting that earnings improvement momentum would actually strengthen despite concerns over a potential labor strike. Dailian reported that a debate over the distribution of Samsung Electronics' operating profit — specifically around performance-based bonuses — is emerging as a core issue. Whether Samsung Electronics can sustain its profitability recovery alongside the broader semiconductor cycle upturn remains a central focus for the market.


InteliView In-Depth Analysis

Loading...

Frequently Asked Questions

Why did Ondas (ONDS) shares surge today?

Ondas posted record quarterly revenue in its latest earnings report, delivering an earnings surprise by beating consensus estimates. According to The Motley Fool, expanding demand for drone and rail automation solutions was the primary driver of the outperformance, and shares rallied sharply immediately following the announcement.

How many companies filed earnings reports with the SEC on May 15, 2026?

A total of 25 companies submitted SEC 8-K Item 2.02 (official earnings release) filings on that date, spanning diverse sectors including aviation, drones, biotech, healthcare, and energy — among them Sky Harbour, York Space Systems, Ondas, Aveanna Healthcare, Legence, and Sangamo Therapeutics.

Which biotech companies are included in today's SEC earnings filings?

Eight biotech companies reported quarterly results via SEC 8-K Item 2.02 filings: Keros Therapeutics (KROS), Celcuity (CELC), Jasper Therapeutics (JSPR), Dogwood Therapeutics (DWTX), Sangamo Therapeutics (SGMO), Benitec Biopharma (BNTC), Invivyd (IVVD), and First Tracks Biotherapeutics (TRAX). As most are clinical-stage companies, R&D expenditure and cash runway are the key metrics to watch.

Justin Jeon
Author

Justin Jeon

Topics
FREE MEMBERSHIP

Did you find this useful?

Sign up to bookmark articles, follow gurus, and manage your portfolio — all for free.

Guru trade alerts
Portfolio tracker
Article bookmarks

Related Articles

Wall Street's Defining Moments

See more
Browse defining moments

Insights

INTELIVIEW NEWSLETTER

Smart Money Briefing

Weekly summaries of Wall Street guru moves and crypto whale activity.